Education
About Us
Working with TipRanks
Follow Us
S2Medical AB Class B (DE:S21)
FRANKFURT:S21
S21 Stock Chart & Stats
$0.01
$0.00(0.00%)
At close: 4:00 PM EST
$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range― - ―
Previous CloseN/A
Volume0.00
Average Volume (3M)N/A
Market Cap
€670.48K
Enterprise Value$9.60M
Total Cash (Recent Filing)€1.29M
Total Debt (Recent Filing)€0.00
Price to Earnings (P/E)―
Beta13.99
Next Earnings
Feb 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding836,139,600
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.50
Price to Sales (P/S)0.39
P/FCF Ratio2.36
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
S21 FAQ
What was S2Medical AB Class B’s price range in the past 12 months?
Currently, no data Available
What is S2Medical AB Class B’s market cap?
S2Medical AB Class B’s market cap is €670.48K.
When is S2Medical AB Class B’s upcoming earnings report date?
S2Medical AB Class B’s upcoming earnings report date is Feb 20, 2026 which is in 33 days.
How were S2Medical AB Class B’s earnings last quarter?
S2Medical AB Class B released its earnings results on Dec 01, 2025. The company reported $0 earnings per share for the quarter, the consensus estimate of N/A by $0.
Is S2Medical AB Class B overvalued?
According to Wall Street analysts S2Medical AB Class B’s price is currently Overvalued.
Does S2Medical AB Class B pay dividends?
S2Medical AB Class B does not currently pay dividends.
What is S2Medical AB Class B’s EPS estimate?
S2Medical AB Class B’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does S2Medical AB Class B have?
S2Medical AB Class B has 836,139,600 shares outstanding.
What happened to S2Medical AB Class B’s price movement after its last earnings report?
S2Medical AB Class B reported an EPS of $0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went up 100%.
Which hedge fund is a major shareholder of S2Medical AB Class B?
Currently, no hedge funds are holding shares in DE:S21
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
S2Medical AB Class B
S2Medical AB (publ) develops, produces, and sells wound healing products for burns and chronic wounds. It offers INSTAQRETT, a sterile single use mechanical debridement tool; EPIPROTECT SafeStop for blood stilling; Instagraft, a single-use medical device for the treatment of chronic and complicated wounds; EPIPROTECT tissue substitutes; and washable, waterproof, and self-adhesive bandages under the INSTABIND brand name. The company also distributes Silverlon dressings that deliver silver ions into the wound. In addition, it operates wound healing center under the S2Clinic name. The company was founded in 2013 and is headquartered in Linköping, Sweden.